These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. Harisinghani MG; Saksena M; Ross RW; Tabatabaei S; Dahl D; McDougal S; Weissleder R Urology; 2005 Nov; 66(5):1066-71. PubMed ID: 16286125 [TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal lymph node dissection in patients with high risk testicular cancer. Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227 [TBL] [Abstract][Full Text] [Related]
15. Is adjuvant chemotherapy following retroperitoneal lymph node dissection for nonseminomatous testis cancer necessary? Donohue JP; Einhorn LH; Williams SD Urol Clin North Am; 1980 Oct; 7(3):747-56. PubMed ID: 6161464 [No Abstract] [Full Text] [Related]
16. [Testicular tumor--retroperitoneal lymph node excision successful in patients with stage I nonseminomatous cancer with or without vascular invasion]. Brudermanns B Aktuelle Urol; 2007 Jan; 38(1):1-2. PubMed ID: 17290323 [No Abstract] [Full Text] [Related]